Hiroaki Harada, Kazuaki Miyamoto, Yoshinori Yamashita, Kikuo Nakano, Kiyomi Taniyama, Yoshihiro Miyata, Hideki Ohdan and Morihito Okada Methylation of breast cancer susceptibility gene 1 (BRCA1) predicts recurrence in patients with curatively resected stage I non–small cell lung cancer Cancer 119
Article first published online: 18 JAN 2013 | DOI: 10.1002/cncr.27754
Molecular biomarkers that can accurately predict prognosis need to be identified to improve clinical outcomes. Methylated BRCA1 (breast cancer susceptibility gene 1) is a potential biomarker that predicts the outcome of disease after curative resection of stage I non–small cell lung cancer.
Complete the form below and we will send an e-mail message containing a link to the selected article on your behalf
Required = Required Field
Copyright © 1999–2013 John Wiley & Sons, Inc. All Rights Reserved.